Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants Cellular Dynamics $500K to Develop Cell Lines for Cardiotoxicity Testing

NEW YORK (GenomeWeb News) – Cellular Dynamics International has landed a small business innovation research grant of $500,000 from the National Institutes of Health to develop pluripotent stem-cell derived human heart cells.
The Madison, Wis.-based developer of tools for predictive screening and drug research said today that the cardiomyocytes it is developing can be used in modeling studies of the early stages of cardiotoxicty. 
The company said that this is the second SBIR grant it has received from NIH, and that the two now total $1 million in funding.
CDI will use pluripotent stem cells to derive pure populations of cardiomyocytes, which it will use to develop preclinical models to predict which drugs may be toxic to the human heart.
Such models could “significantly reduce the chances of a cardiotoxic compound from ever reaching a clinical population, thus improving the overall efficiency and safety of the drug development process,” the company said.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.